Embla Medical hf.
OSSFF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $25,789 | $21,246 | $12,230 | $18,185 |
| Dep. & Amort. | $15,904 | $15,169 | $14,325 | $14,619 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $5,131 | -$15,507 | -$13,264 | $7,415 |
| Other Non-Cash | -$397 | $1,739 | $520 | $1,734 |
| Operating Cash Flow | $46,427 | $22,647 | $13,811 | $41,952 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$7,869 | -$10,430 | -$6,172 | -$8,002 |
| Net Acquisitions | -$4,153 | -$1,073 | -$3,239 | -$1,364 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$5,210 | $3,902 | -$2,230 | $4,505 |
| Investing Cash Flow | -$17,231 | -$7,602 | -$11,641 | -$4,861 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$11,175 | -$4,883 | $8,706 | -$21,570 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$2,672 | -$3,058 | -$1,277 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$6,996 | -$6,860 | -$6,460 | -$6,438 |
| Financing Cash Flow | -$20,842 | -$14,800 | $969 | -$28,008 |
| Forex Effect | -$370 | $2,043 | $2,438 | -$4,132 |
| Net Chg. in Cash | $7,984 | $2,288 | $5,577 | $4,951 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $94,072 | $91,784 | $86,207 | $81,256 |
| End Cash | $102,055 | $94,072 | $91,784 | $86,207 |
| Free Cash Flow | $41,479 | $14,937 | $10,122 | $37,058 |